Table 2 Multivariate analysis of disease-free survival
From: Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
Prognostic factor | β | P | Relative risk | 95% confidence interval |
|---|---|---|---|---|
Overall histology | ||||
Tumor MMP-9 expression | 0.286 | 0.142 | 1.332 | 0.908–1.952 |
Lymphovascular invasion | 0.586 | 0.028 | 1.797 | 1.065–3.032 |
Pathologic stage (I vs. II) | 1.264 | 0.000 | 3.538 | 2.259–5.541 |
Pathologic stage (I vs. IIIA) | 1.404 | 0.000 | 4.070 | 2.450–6.760 |
Tumor histology (squamous cell carcinoma vs. adeno) | 0.685 | 0.002 | 1.985 | 1.299–3.033 |
Squamous cell carcinoma | ||||
Tumor MMP-9 expression | −0.411 | 0.309 | 0.663 | 0.301–1.463 |
Adenocarcinoma | ||||
Tumor MMP-9 expression | 0.580 | 0.035 | 1.787 | 1.041–3.067 |